pmc-enju-pas Home  

PMC:3586680 / 89-1077 JSONTXT 21 Projects

Annnotations TAB TSV DIC JSON TextAE Lectin_function

Id Subject Object Predicate Lexical cue
T177 0-5 NN denotes Tumor
T178 6-16 NN denotes suppressor
T179 17-20 NN denotes p53
T180 21-24 VB denotes are
T181 25-35 RB denotes frequently
T182 36-43 VB denotes mutated
T183 44-46 IN denotes in
T184 47-60 NN denotes glioblastomas
T185 61-62 -LRB- denotes (
T186 62-66 NN denotes GBMs
T187 66-67 -RRB- denotes )
T188 68-71 CC denotes and
T189 72-79 VB denotes appears
T190 80-82 TO denotes to
T191 83-93 VB denotes contribute
T192 93-94 -COMMA- denotes ,
T193 95-97 IN denotes in
T194 98-102 NN denotes part
T195 102-103 -COMMA- denotes ,
T196 104-106 TO denotes to
T197 107-117 NN denotes resistance
T198 118-120 TO denotes to
T199 121-133 NN denotes temozolomide
T200 134-135 -LRB- denotes (
T201 135-138 NN denotes TMZ
T202 138-139 -RRB- denotes )
T203 140-143 CC denotes and
T204 144-155 JJ denotes therapeutic
T205 156-161 NN denotes drugs
T206 163-165 JJ denotes WW
T207 166-183 JJ denotes domain-containing
T208 184-198 NN denotes oxidoreductase
T209 199-203 NN denotes WWOX
T210 204-205 -LRB- denotes (
T211 205-208 NN denotes FOR
T212 209-211 CC denotes or
T213 212-216 NN denotes WOX1
T214 216-217 -RRB- denotes )
T215 218-220 VB denotes is
T216 221-222 DT denotes a
T217 223-235 JJ denotes proapoptotic
T218 236-243 NN denotes protein
T219 244-247 CC denotes and
T220 248-250 VB denotes is
T221 251-261 VB denotes considered
T222 262-264 IN denotes as
T223 265-266 DT denotes a
T224 267-272 NN denotes tumor
T225 273-283 NN denotes suppressor
T226 285-289 NN denotes Loss
T227 290-292 IN denotes of
T228 293-297 NN denotes WWOX
T229 298-302 NN denotes gene
T230 303-313 NN denotes expression
T231 314-316 VB denotes is
T232 317-327 RB denotes frequently
T233 328-332 VB denotes seen
T234 333-335 IN denotes in
T235 336-345 JJ denotes malignant
T236 346-352 NN denotes cancer
T237 353-358 NN denotes cells
T238 359-362 JJ denotes due
T239 363-365 TO denotes to
T240 366-374 NN denotes promoter
T241 375-391 NN denotes hypermethylation
T242 391-392 -COMMA- denotes ,
T243 393-400 JJ denotes genetic
T244 401-412 NN denotes alterations
T245 412-413 -COMMA- denotes ,
T246 414-417 CC denotes and
T247 418-431 JJ denotes translational
T248 432-440 NN denotes blockade
T249 442-454 RB denotes Intriguingly
T250 454-455 -COMMA- denotes ,
T251 456-463 JJ denotes ectopic
T252 464-474 NN denotes expression
T253 475-477 IN denotes of
T254 478-482 JJ denotes wild
T255 483-487 NN denotes type
T256 488-492 NN denotes WWOX
T257 493-507 RB denotes preferentially
T258 508-515 VB denotes induces
T259 516-525 NN denotes apoptosis
T260 526-528 IN denotes in
T261 529-534 JJ denotes human
T262 535-547 NN denotes glioblastoma
T263 548-553 NN denotes cells
T264 554-563 VB denotes harboring
T265 564-570 JJ denotes mutant
T266 571-574 NN denotes p53
T267 576-580 NN denotes WWOX
T268 581-583 VB denotes is
T269 584-589 VB denotes known
T270 590-592 TO denotes to
T271 593-603 RB denotes physically
T272 604-608 VB denotes bind
T273 609-612 CC denotes and
T274 613-622 VB denotes stabilize
T275 623-627 JJ denotes wild
T276 628-632 NN denotes type
T277 633-636 NN denotes p53
T278 638-642 RB denotes Here
T279 642-643 -COMMA- denotes ,
T280 644-646 PRP denotes we
T281 647-654 VB denotes provide
T282 655-657 DT denotes an
T283 658-666 NN denotes overview
T284 667-670 IN denotes for
T285 671-674 DT denotes the
T286 675-682 VB denotes updated
T287 683-692 NN denotes knowledge
T288 693-695 IN denotes in
T289 696-699 NN denotes p53
T290 700-703 CC denotes and
T291 704-708 NN denotes WWOX
T292 708-709 -COMMA- denotes ,
T293 710-713 CC denotes and
T294 714-723 VB denotes postulate
T295 724-733 JJ denotes potential
T296 734-743 NN denotes scenarios
T297 744-748 IN denotes that
T298 749-753 JJ denotes wild
T299 754-758 NN denotes type
T300 759-762 CC denotes and
T301 763-769 JJ denotes mutant
T302 770-773 NN denotes p53
T303 773-774 -COMMA- denotes ,
T304 775-777 CC denotes or
T305 778-786 NN denotes isoforms
T306 786-787 -COMMA- denotes ,
T307 788-796 VB denotes modulate
T308 797-800 DT denotes the
T309 801-810 JJ denotes apoptotic
T310 811-819 NN denotes function
T311 820-822 IN denotes of
T312 823-827 NN denotes WWOX
T313 829-831 PRP denotes We
T314 832-839 VB denotes propose
T315 840-844 IN denotes that
T316 845-855 VB denotes triggering
T317 856-860 NN denotes WWOX
T318 861-871 NN denotes activation
T319 872-874 IN denotes by
T320 875-886 JJ denotes therapeutic
T321 887-892 NN denotes drugs
T322 893-898 IN denotes under
T323 899-902 NN denotes p53
T324 903-913 JJ denotes functional
T325 914-924 NN denotes deficiency
T326 925-927 VB denotes is
T327 928-934 VB denotes needed
T328 935-937 TO denotes to
T329 938-946 VB denotes overcome
T330 947-950 NN denotes TMZ
T331 951-961 NN denotes resistance
T332 962-965 CC denotes and
T333 966-972 VB denotes induce
T334 973-976 NN denotes GBM
T335 977-981 NN denotes cell
T336 982-987 NN denotes death
R100 T237 T234 arg2Of cells,in
R101 T237 T235 arg1Of cells,malignant
R102 T237 T236 arg1Of cells,cancer
R103 T237 T238 arg1Of cells,due
R104 T241 T240 arg1Of hypermethylation,promoter
R105 T241 T242 arg1Of hypermethylation,","
R106 T242 T246 arg1Of ",",and
R107 T244 T242 arg2Of alterations,","
R108 T244 T243 arg1Of alterations,genetic
R109 T246 T239 arg2Of and,to
R110 T246 T245 arg1Of and,","
R111 T248 T246 arg2Of blockade,and
R112 T248 T247 arg1Of blockade,translational
R113 T252 T251 arg1Of expression,ectopic
R114 T252 T253 arg1Of expression,of
R115 T252 T258 arg1Of expression,induces
R116 T256 T253 arg2Of WWOX,of
R117 T256 T254 arg1Of WWOX,wild
R118 T256 T255 arg1Of WWOX,type
R119 T258 T249 arg1Of induces,Intriguingly
R120 T258 T250 arg1Of induces,","
R121 T258 T257 arg1Of induces,preferentially
R122 T258 T260 arg1Of induces,in
R123 T259 T258 arg2Of apoptosis,induces
R124 T263 T260 arg2Of cells,in
R125 T263 T261 arg1Of cells,human
R126 T263 T262 arg1Of cells,glioblastoma
R127 T263 T264 arg1Of cells,harboring
R128 T266 T264 arg2Of p53,harboring
R129 T266 T265 arg1Of p53,mutant
R130 T267 T268 arg1Of WWOX,is
R131 T267 T269 arg2Of WWOX,known
R132 T267 T272 arg1Of WWOX,bind
R133 T267 T274 arg1Of WWOX,stabilize
R134 T269 T268 arg2Of known,is
R135 T272 T273 arg1Of bind,and
R136 T273 T269 arg3Of and,known
R137 T273 T270 arg1Of and,to
R138 T273 T271 arg1Of and,physically
R139 T274 T273 arg2Of stabilize,and
R140 T277 T272 arg2Of p53,bind
R141 T277 T274 arg2Of p53,stabilize
R142 T277 T275 arg1Of p53,wild
R143 T277 T276 arg1Of p53,type
R144 T280 T281 arg1Of we,provide
R145 T280 T294 arg1Of we,postulate
R146 T281 T293 arg1Of provide,and
R147 T283 T281 arg2Of overview,provide
R148 T283 T282 arg1Of overview,an
R149 T283 T284 arg1Of overview,for
R150 T287 T284 arg2Of knowledge,for
R151 T287 T285 arg1Of knowledge,the
R152 T287 T286 arg2Of knowledge,updated
R153 T287 T288 arg1Of knowledge,in
R154 T289 T290 arg1Of p53,and
R155 T290 T288 arg2Of and,in
R156 T291 T290 arg2Of WWOX,and
R157 T293 T278 arg1Of and,Here
R158 T293 T279 arg1Of and,","
R159 T293 T292 arg1Of and,","
R160 T294 T293 arg2Of postulate,and
R161 T296 T294 arg2Of scenarios,postulate
R162 T296 T295 arg1Of scenarios,potential
R163 T296 T297 arg1Of scenarios,that
R164 T299 T298 arg1Of type,wild
R165 T299 T300 arg1Of type,and
R166 T300 T304 arg1Of and,or
R167 T302 T300 arg2Of p53,and
R168 T302 T301 arg1Of p53,mutant
R169 T304 T303 arg1Of or,","
R170 T304 T307 arg1Of or,modulate
R171 T305 T304 arg2Of isoforms,or
R172 T307 T297 arg2Of modulate,that
R173 T307 T306 arg1Of modulate,","
R174 T310 T307 arg2Of function,modulate
R175 T310 T308 arg1Of function,the
R176 T310 T309 arg1Of function,apoptotic
R177 T310 T311 arg1Of function,of
R178 T312 T311 arg2Of WWOX,of
R179 T313 T314 arg1Of We,propose
R180 T318 T316 arg1Of activation,triggering
R181 T318 T317 arg1Of activation,WWOX
R182 T318 T319 arg1Of activation,by
R183 T318 T322 arg1Of activation,under
R184 T318 T326 arg1Of activation,is
R185 T318 T327 arg2Of activation,needed
R186 T321 T319 arg2Of drugs,by
R187 T321 T320 arg1Of drugs,therapeutic
R188 T325 T322 arg2Of deficiency,under
R189 T325 T323 arg1Of deficiency,p53
R190 T325 T324 arg1Of deficiency,functional
R191 T327 T314 arg2Of needed,propose
R192 T327 T315 arg1Of needed,that
R193 T327 T326 arg2Of needed,is
R194 T327 T328 modOf needed,to
R195 T329 T332 arg1Of overcome,and
R196 T331 T329 arg2Of resistance,overcome
R197 T331 T330 arg1Of resistance,TMZ
R198 T332 T328 arg1Of and,to
R199 T333 T332 arg2Of induce,and
R200 T336 T333 arg2Of death,induce
R201 T336 T334 arg1Of death,GBM
R202 T336 T335 arg1Of death,cell
R38 T179 T177 arg1Of p53,Tumor
R39 T179 T178 arg1Of p53,suppressor
R40 T179 T180 arg1Of p53,are
R41 T179 T182 arg2Of p53,mutated
R42 T179 T189 arg1Of p53,appears
R43 T179 T191 arg1Of p53,contribute
R44 T182 T180 arg2Of mutated,are
R45 T182 T181 arg1Of mutated,frequently
R46 T182 T183 arg1Of mutated,in
R47 T182 T188 arg1Of mutated,and
R48 T184 T183 arg2Of glioblastomas,in
R49 T184 T185 arg1Of glioblastomas,(
R50 T186 T185 arg2Of GBMs,(
R51 T187 T185 arg3Of ),(
R52 T189 T188 arg2Of appears,and
R53 T191 T189 arg2Of contribute,appears
R54 T191 T190 arg1Of contribute,to
R55 T191 T192 arg1Of contribute,","
R56 T191 T193 arg1Of contribute,in
R57 T191 T195 arg1Of contribute,","
R58 T191 T196 arg1Of contribute,to
R59 T194 T193 arg2Of part,in
R60 T197 T198 arg1Of resistance,to
R61 T197 T203 arg1Of resistance,and
R62 T199 T198 arg2Of temozolomide,to
R63 T199 T200 arg1Of temozolomide,(
R64 T201 T200 arg2Of TMZ,(
R65 T202 T200 arg3Of ),(
R66 T203 T196 arg2Of and,to
R67 T205 T203 arg2Of drugs,and
R68 T205 T204 arg1Of drugs,therapeutic
R69 T209 T206 arg1Of WWOX,WW
R70 T209 T207 arg1Of WWOX,domain-containing
R71 T209 T208 arg1Of WWOX,oxidoreductase
R72 T209 T210 arg1Of WWOX,(
R73 T209 T215 arg1Of WWOX,is
R74 T209 T220 arg1Of WWOX,is
R75 T209 T221 arg2Of WWOX,considered
R76 T211 T212 arg1Of FOR,or
R77 T212 T210 arg2Of or,(
R78 T213 T212 arg2Of WOX1,or
R79 T214 T210 arg3Of ),(
R80 T215 T219 arg1Of is,and
R81 T218 T215 arg2Of protein,is
R82 T218 T216 arg1Of protein,a
R83 T218 T217 arg1Of protein,proapoptotic
R84 T221 T219 arg2Of considered,and
R85 T221 T220 arg2Of considered,is
R86 T221 T222 arg1Of considered,as
R87 T225 T222 arg2Of suppressor,as
R88 T225 T223 arg1Of suppressor,a
R89 T225 T224 arg1Of suppressor,tumor
R90 T226 T227 arg1Of Loss,of
R91 T226 T231 arg1Of Loss,is
R92 T226 T233 arg2Of Loss,seen
R93 T230 T227 arg2Of expression,of
R94 T230 T228 arg1Of expression,WWOX
R95 T230 T229 arg1Of expression,gene
R96 T233 T231 arg2Of seen,is
R97 T233 T232 arg1Of seen,frequently
R98 T233 T234 arg1Of seen,in
R99 T233 T239 arg1Of seen,to